1. Home
  2. PSN vs BMRN Comparison

PSN vs BMRN Comparison

Compare PSN & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parsons Corporation

PSN

Parsons Corporation

HOLD

Current Price

$67.71

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$59.83

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSN
BMRN
Founded
1944
1996
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
10.0B
IPO Year
2019
1999

Fundamental Metrics

Financial Performance
Metric
PSN
BMRN
Price
$67.71
$59.83
Analyst Decision
Strong Buy
Buy
Analyst Count
14
16
Target Price
$84.00
$87.94
AVG Volume (30 Days)
1.3M
2.2M
Earning Date
05-13-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
3.77
N/A
EPS
2.20
1.80
Revenue
$6,364,245,000.00
$1,313,646,000.00
Revenue This Year
$6.45
$11.04
Revenue Next Year
$7.69
$9.25
P/E Ratio
$29.78
$34.29
Revenue Growth
N/A
17.62
52 Week Low
$54.56
$50.76
52 Week High
$89.50
$73.51

Technical Indicators

Market Signals
Indicator
PSN
BMRN
Relative Strength Index (RSI) 53.15 51.40
Support Level $66.62 $56.08
Resistance Level $70.39 $60.52
Average True Range (ATR) 2.32 2.62
MACD 0.33 -0.09
Stochastic Oscillator 75.47 28.57

Price Performance

Historical Comparison
PSN
BMRN

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: